Startups
Edit
BioAegis Therapeutics, Inc.
http://www.bioaegistherapeutics.com/Last activity: 22.03.2022
Active
Commercializing Ground Breaking Discoveries in Inflammation and Infection
BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications.
BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications.
Overview
Location
United States, New Jersey, North Brunswick Township
Employees
11-50
Phone
+1 203-952-6373
Total raised
$34M
Founded date
2011
Funding Rounds 4
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jun 24, 2020 | Funding round | $5M | |
| Sep 18, 2018 | Funding round | $4M | |
| Feb 8, 2013 | Funding round | $3M |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2018 | BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round | MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired Pneumonia (CAP) in Austral... |
| Feb 8, 2013 | Biotech startup developing therapeutic to combat sepsis raises $3 million | Biogen licensed the technology in 1994 and had tried to develop it to treat patients with cystic fibrosis. Critical Biologics had tried to develop it for intensive care unit patients to boost the gelsolin levels in these patients and decrea... |
| Feb 8, 2013 | BioAegis Therapeutics Raises $3M | BioAegis Therapeutics, a Boston, MA-based therapeutics startup, completed a funding of over $3m. Backers included Family Offices and other unnamed private investors. Founded in 2011 Dr. Thomas Stossel, director of Translational Medicine at ... |
| Biotech startup developing therapeutic to combat sepsis raises $3 million | A biotechnology startup developing an anti-inflammatory therapeutic that uses a protein component of plasma to treat sepsis and other conditions has raised $3 million, according to an amended Form D filing with the U.S. Securities and Excha... |
Reviews 0
FAQ about BioAegis Therapeutics, Inc.
When was BioAegis Therapeutics, Inc. founded?
BioAegis Therapeutics, Inc. was founded in 2011.
How much funding has BioAegis Therapeutics, Inc. raised?
BioAegis Therapeutics, Inc. has raised $34M in total across 4 funding rounds.
What funding rounds has BioAegis Therapeutics, Inc. raised?
Parsers VC lists 4 funding rounds of BioAegis Therapeutics, Inc., among them a funding round of $5M on Jun 24, 2020, a funding round of $4M on Sep 18, 2018 and a funding round of $3M on Feb 8, 2013.
What has the press written about BioAegis Therapeutics, Inc.?
Parsers VC has collected 5 articles mentioning BioAegis Therapeutics, Inc., among them “BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round” (Sep 18, 2018) and “Biotech startup developing therapeutic to combat sepsis raises $3 million” (Feb 8, 2013).
Is BioAegis Therapeutics, Inc. still active?
Yes, BioAegis Therapeutics, Inc. is active; its latest activity on Parsers VC dates from Mar 22, 2022.